87 related articles for article (PubMed ID: 6308150)
1. Pharmacological and therapeutic actions of GABA receptor agonists.
Zivkovic B; Scatton B; Worms P; Lloyd KG; Bartholini G
J Neural Transm Suppl; 1983; 18():319-26. PubMed ID: 6308150
[TBL] [Abstract][Full Text] [Related]
2. GABA receptor agonists: pharmacological spectrum and therapeutic actions.
Bartholini G
Med Res Rev; 1985; 5(1):55-75. PubMed ID: 2984490
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of the GABAergic system: effects of progabide, a GABA receptor agonist.
Bartholini G
Psychoneuroendocrinology; 1984; 9(2):135-40. PubMed ID: 6089242
[TBL] [Abstract][Full Text] [Related]
4. [Implications of GABAergic synapses in neuropsychiatry].
Lloyd KG; Perrault G; Zivkovic B
J Pharmacol; 1985; 16 Suppl 2():5-27. PubMed ID: 2867252
[TBL] [Abstract][Full Text] [Related]
5. gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor.
Lloyd KG; Arbilla S; Beaumont K; Briley M; De Montis G; Scatton B; Langer SZ; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):672-7. PubMed ID: 6121050
[TBL] [Abstract][Full Text] [Related]
6. gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas.
Scatton B; Zivkovic B; Dedek J; Lloyd KG; Constantinidis J; Tissot R; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):678-88. PubMed ID: 6278130
[No Abstract] [Full Text] [Related]
7. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
Worms P; Depoortere H; Durand A; Morselli PL; Lloyd KG; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):660-71. PubMed ID: 6278129
[TBL] [Abstract][Full Text] [Related]
8. Experimental basis for the antidepressant action of the GABA receptor agonist progabide.
Bartholini G
Neurosci Lett; 1984 Jun; 47(3):351-5. PubMed ID: 6089056
[TBL] [Abstract][Full Text] [Related]
9. Clinical activity of GABA agonists in neuroleptic- and L-dopa-induced dyskinesia.
Morselli PL; Fournier V; Bossi L; Musch B
Psychopharmacology Suppl; 1985; 2():128-36. PubMed ID: 2860656
[TBL] [Abstract][Full Text] [Related]
10. Indications for the use of gamma-aminobutyric acid (GABA)-agonists in convulsant disorders.
Lloyd KG; Munari C; Worms P; Bossi L; Morselli PL
Prog Clin Biol Res; 1983; 124():285-97. PubMed ID: 6410408
[TBL] [Abstract][Full Text] [Related]
11. Progabide: a new GABA-mimetic agent in clinical use.
Bergmann KJ
Clin Neuropharmacol; 1985; 8(1):13-26. PubMed ID: 2983890
[No Abstract] [Full Text] [Related]
12. Neurochemical and neuropharmacological indications for the involvement of GABA and glycine receptors in neuropsychiatric disorders.
Lloyd KG; DeMontis G; Broekkamp CL; Thuret F; Worms P
Adv Biochem Psychopharmacol; 1983; 37():137-48. PubMed ID: 6138947
[TBL] [Abstract][Full Text] [Related]
13. Effects of gabaergic and serotoninergic systems on hypothalamic content of catecholamines during sexual development in female rats.
Rondina D; Ponzo OJ; Szwarcfarb B; Carbone S; Scacchi P; Moguilevsky JA
Neuro Endocrinol Lett; 2003; 24(1-2):46-9. PubMed ID: 12743531
[TBL] [Abstract][Full Text] [Related]
14. GABA system, GABA receptor agonists and dyskinesia.
Bartholini G
Mod Probl Pharmacopsychiatry; 1983; 21():143-54. PubMed ID: 6318094
[No Abstract] [Full Text] [Related]
15. [Progabide treatment of a case of the syndrome of painful legs and moving toes].
Bovier P; Hilleret H; Tissot R
Rev Neurol (Paris); 1985; 141(5):422-4. PubMed ID: 2996110
[TBL] [Abstract][Full Text] [Related]
16. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
Bishnoi M; Chopra K; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775
[TBL] [Abstract][Full Text] [Related]
17. Differential sensitivity of ethanol withdrawal signs in the rat to gamma-aminobutyric acid (GABA)mimetics: blockade of audiogenic seizures but not forelimb tremors.
Frye GD; McCown TJ; Breese GR
J Pharmacol Exp Ther; 1983 Sep; 226(3):720-5. PubMed ID: 6310080
[TBL] [Abstract][Full Text] [Related]
18. Receptors and the mechanism of action of ECT.
Lerer B; Belmaker RH
Biol Psychiatry; 1982 Apr; 17(4):497-511. PubMed ID: 6282347
[No Abstract] [Full Text] [Related]
19. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
Miczek KA; Fish EW; De Bold JF; De Almeida RM
Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
[TBL] [Abstract][Full Text] [Related]
20. Is there a common denominator for the antimanic effect of lithium and anticonvulsants?
Waldmeier PC
Pharmacopsychiatry; 1987 Mar; 20(2):37-47. PubMed ID: 3035590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
